All Stories

  1. Same meat, different gravy: ignore the new names of mycobacteria

    Article • European Respiratory Journal, July 2019, European Respiratory Society (ERS)

    Dr Enrico Tortoli, Dirk Wagner

  2. Treatment of a broncho-esophageal fistula complicated by severe ARDS

    Article • Infection, November 2018, Springer Science + Business Media

    Dirk Wagner

  3. Clofazimine does not lead to significant QT interval prolongation: a multicentre study

    Article • European Respiratory Journal, November 2018, European Respiratory Society (ERS)

    Dirk Wagner

  4. Case Report and Genetic Sequence Analysis of Candidatus Borrelia kalaharica, Southern Africa

    Article • Emerging Infectious Diseases, September 2018, Centers for Disease Control and Prevention (CDC)

    Dirk Wagner

  5. Diabetes und Tuberkulose

    Article • Der Diabetologe, May 2018, Springer Science + Business Media

    Dirk Wagner

  6. Treatment outcome definitions for nontuberculous mycobacterial pulmonary disease

    Article • European Respiratory Journal, March 2018, European Respiratory Society (ERS)

    Jakko van Ingen, Professor Rachel M Thomson, Dr Enrico Tortoli, Dirk Wagner

  7. Photo Quiz: Pneumonia and Pyogenic Skin Abscesses in a 79-Year-Old Man

    Article • Journal of Clinical Microbiology, January 2018, ASM Journals

    Dirk Wagner

  8. Answer to February 2018 Photo Quiz

    Article • Journal of Clinical Microbiology, January 2018, ASM Journals

    Dirk Wagner

  9. Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in Europe: A tuberculosis network European Trialsgroup (TBNET) study

    Article • Respiratory Medicine, November 2017, Elsevier

    Dirk Wagner, MD, PhD Jerker Jonsson

  10. Global outbreak of severe Mycobacterium chimaera disease after cardiac surgery: a molecular epidemiological study

    Article • The Lancet Infectious Diseases, October 2017, Elsevier

    Dirk Wagner

  11. Physicians don't follow guidelines for the treatment of nontuberculous mycobacterial lung disease

    Article • European Respiratory Journal, December 2016, European Respiratory Society (ERS)

    Jakko van Ingen, Dirk Wagner

  12. DNA Damage Signaling Instructs Polyploid Macrophage Fate in Granulomas

    Article • Cell, November 2016, Elsevier

    Professor Torsten Goldmann, Dirk Wagner

  13. Prevalence of Nontuberculous Mycobacterial Pulmonary Disease, Germany, 2009 – 2014

    Article • Pneumologie, October 2016, Thieme Publishing Group

    Dirk Wagner

  14. Heater–cooler units: contamination of crucial devices in cardiothoracic surgery

    Article • Journal of Hospital Infection, July 2016, Elsevier

    Dirk Wagner

  15. Prevalence of Nontuberculous Mycobacterial Pulmonary Disease, Germany, 2009–2014

    Article • Emerging Infectious Diseases, June 2016, Centers for Disease Control and Prevention (CDC)

    Dirk Wagner

  16. Thermostability of IFN-γ and IP-10 release assays for latent infection with Mycobacterium tuberculosis: A TBnet study

    Article • Tuberculosis, May 2016, Elsevier

    Dirk Wagner

  17. Should all adult cystic fibrosis patients with repeated nontuberculous mycobacteria cultures receive specific treatment? A 10-year case–control study

    Article • European Respiratory Journal, February 2016, European Respiratory Society (ERS)

    Professor Mathias W Pletz, Dirk Wagner

  18. Viral Load and Risk of Tuberculosis in HIV Infection

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, February 2016, Wolters Kluwer Health

    Dr Frank van Leth, Dirk Wagner

  19. Genetic diversity of clinical Mycobacterium avium subsp. hominissuis and Mycobacterium intracellulare isolates causing pulmonary diseases recovered from different geographical regions

    Article • Infection Genetics and Evolution, December 2015, Elsevier

    Dirk Wagner

  20. A randomized, open-label, multicenter study of liposomal amikacin for inhalation in adult patients with nontuberculous mycobacteria (NTM) lung infections caused bymycobacterium aviumcomplex (MAC)

    Article • September 2015, European Respiratory Society (ERS)

    Dirk Wagner

  21. Mycobacterium chimaera infections after cardiopulmonary bypass surgery

    Article • European Heart Journal, July 2015, European Society of Cardiology

    Dr Barbara Hasse, Dirk Wagner

  22. Importierte Histoplasmose

    Article • DMW - Deutsche Medizinische Wochenschrift, June 2015, Thieme Publishing Group

    Dirk Wagner

  23. Superior Sensitivity ofEx VivoIFN-γ Release Assays as Compared to Skin Testing in Immunocompromised Patients

    Article • American Journal of Transplantation, May 2015, Wiley

    Dirk Wagner

  24. Non-tuberculous mycobacteria in children: muddying the waters of tuberculosis diagnosis

    Article • The Lancet Respiratory Medicine, March 2015, Elsevier

    Dirk Wagner

  25. Primary Cutaneous Cryptococcosis in an Eight-year-old Immunocompetent Child: How to Treat?

    Article • Klinische Pädiatrie, January 2015, Thieme Publishing Group

    Dr Dominic Lenz, Dirk Wagner

  26. Risk Assessment of Tuberculosis in Immunocompromised Patients. A TBNET Study

    Article • American Review of Respiratory Disease, November 2014, American Thoracic Society

    Dr Frank van Leth, Dirk Wagner

  27. Diagnostic Accuracy of Computer-Aided Detection of Pulmonary Tuberculosis in Chest Radiographs: A Validation Study from Sub-Saharan Africa

    Article • PLoS ONE, September 2014, PLOS

    Dr Francis A Mhimbira, Dirk Wagner

  28. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement

    Article • European Respiratory Journal, March 2014, European Respiratory Society (ERS)

    Dr Valeriu Crudu, Dr Valeriu Crudu, Dr Frank van Leth, Dr Enrico Tortoli, Dirk Wagner

  29. Mycobacterium genavense specific mesenteritic syndrome in HIV-infected patients

    Article • AIDS, November 2013, Wolters Kluwer Health

    Dirk Wagner

  30. Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)

    Article • Infection, September 2013, Springer Science + Business Media

    Dirk Wagner

  31. Mycobacterium genavense specific mesenteritic syndrome in HIV-infected patients - an new entity of retractile mesenteritis?

    Article • AIDS, August 2013, Wolters Kluwer Health

    Dirk Wagner

  32. Mycobacterium genavense specific mesenteritic syndrome in HIV-infected patients - an new entity of retractile mesenteritis?

    Article • Seminars in Musculoskeletal Radiology, July 2013, Thieme Publishing Group

    Dirk Wagner

  33. Human Infection with Marten Tapeworm

    Article • Emerging Infectious Diseases, July 2013, Centers for Disease Control and Prevention (CDC)

    Dirk Wagner

  34. Burden and trends of hospitalisations associated with pulmonary non-tuberculous mycobacterial infections in Germany, 2005–2011

    Article • BMC Infectious Diseases, May 2013, Springer Science + Business Media

    Dirk Wagner

  35. Manifestation of an Abdominal Immune Reconstitution Inflammatory Syndrome Associated with a Nontuberculous Mycobacterial Infection - A Case Report

    Article • Seminars in Musculoskeletal Radiology, May 2013, Thieme Publishing Group

    Dirk Wagner

  36. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study

    Article • European Respiratory Journal, April 2013, European Respiratory Society (ERS)

    Professor Rachel M Thomson, Dr Mateja Jankovic Makek, Dirk Wagner, Dr Enrico Tortoli

  37. Pulmonary diseases caused by non-tuberculous mycobacteria

    Article • December 2012, European Respiratory Society (ERS)

    Dirk Wagner

  38. Tbnet — Collaborative research on tuberculosis in Europe

    Article • European Journal of Microbiology and Immunology, December 2012, Akademiai Kiado

    Dirk Wagner

  39. The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement

    Article • European Respiratory Journal, April 2012, European Respiratory Society (ERS)

    Dirk Wagner

  40. Development of tuberculosis in immunocompromised patients with a positive tuberculosis-specific IGRA [Short communication]

    Article • The International Journal of Tuberculosis and Lung Disease, April 2012, International Union Against Tuberculosis and Lung Disease

    Dirk Wagner

  41. "Interferon-  release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis." R. Diel, D. Goletti, G. Ferrara, G. Bothamley, D. Cirillo, B. Kampmann, C. Lange, M. Losi, R. Markova, G.B. Migliori,...

    Article • European Respiratory Journal, February 2012, European Respiratory Society (ERS)

    Dirk Wagner, Dr Giovanni Ferrara

  42. Fatal hemophagocytic syndrome in a patient with a previously well-controlled asymptomatic HIV infection after EBV reactivation

    Article • Journal of Infection, January 2012, Elsevier

    Dirk Wagner

  43. Epidemiologie der nichttuberkulösen mykobakteriellen Erkrankungen in Deutschland und weltweit

    Article • Der Pneumologe, November 2011, Springer Science + Business Media

    Dirk Wagner

  44. β-d-Glucan kinetics for the assessment of treatment response in Pneumocystis jirovecii pneumonia

    Article • Clinical Microbiology and Infection, July 2011, Elsevier

    Dirk Wagner

  45. Tuberkulose und nicht-tuberkulöse Mykobakteriose

    Article • DMW - Deutsche Medizinische Wochenschrift, March 2011, Thieme Publishing Group

    Dirk Wagner

  46. Interferon-  release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis

    Article • European Respiratory Journal, October 2010, European Respiratory Society (ERS)

    Dr Giovanni Ferrara, Dirk Wagner

  47. Einführung des Interferon-γ-Release Assay bei Tuberkulose-Umgebungsuntersuchungen – ein 2-Jahres Projekt in Niedersachsen

    Article • Das Gesundheitswesen, September 2010, Thieme Publishing Group

    Dirk Wagner

  48. Development of a standardised tool to survey MDR-/XDR-TB case management in Europe

    Article • European Respiratory Journal, June 2010, European Respiratory Society (ERS)

    Dirk Wagner

  49. Indeterminate results of a tuberculosis-specific interferon-  release assay in immunocompromised patients

    Article • European Respiratory Journal, May 2010, European Respiratory Society (ERS)

    Dirk Wagner

  50. Virulence-related Mycobacterium avium subsp hominissuis MAV_2928 gene is associated with vacuole remodeling in macrophages

    Article • BMC Microbiology, April 2010, Springer Science + Business Media

    Dr Lia Danelishvili, Dirk Wagner

  51. Paenibacillus larvaeBacteremia in Injection Drug Users

    Article • Emerging Infectious Diseases, March 2010, Centers for Disease Control and Prevention (CDC)

    Dirk Wagner

  52. Differential activity of innate defense antimicrobial peptides against Nocardia species

    Article • BMC Microbiology, January 2010, Springer Science + Business Media

    Dirk Wagner

  53. Mortality of S. aureus bacteremia and infectious diseases specialist consultation – A study of 521 patients in Germany

    Article • Journal of Infection, October 2009, Elsevier

    Dirk Wagner

  54. Identification of virulence determinants of Mycobacterium avium that impact on the ability to resist host killing mechanisms

    Article • Journal of Medical Microbiology, September 2009, Society for General Microbiology

    Dr Lia Danelishvili, Dirk Wagner

  55. Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany

    Article • Emerging Infectious Diseases, November 2008, Centers for Disease Control and Prevention (CDC)

    Dirk Wagner

  56. Vergleich von Tuberkulin-Hauttests und Interferon-Gamma-Tests im Rahmen einer Umgebungsuntersuchung in einer JVA

    Article • Das Gesundheitswesen, November 2008, Thieme Publishing Group

    Dirk Wagner

  57. Relapses vs. reactions in multibacillary leprosy: proposal of new relapse criteria

    Article • Tropical Medicine & International Health, April 2008, Wiley

    Dirk Wagner

  58. Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis

    Article • Journal of Antimicrobial Chemotherapy, March 2008, Oxford University Press (OUP)

    Professor Miguel Viveiros, Dirk Wagner

  59. Extensiv-resistente Tuberkulose (XDR-TB)

    Article • DMW - Deutsche Medizinische Wochenschrift, February 2008, Thieme Publishing Group

    Dirk Wagner

  60. Stellenwert der T-Zell-Interferon-γ-Sekretionstests in der Tuberkulosediagnostik

    Article • DMW - Deutsche Medizinische Wochenschrift, February 2008, Thieme Publishing Group

    Dirk Wagner

  61. P1515 Relapses versus reactions in multibacillary leprosy: proposal of new relapse criteria

    Article • International Journal of Antimicrobial Agents, March 2007, Elsevier

    Dirk Wagner

  62. Elemental analysis of the Mycobacterium avium phagosome in Balb/c mouse macrophages

    Article • Biochemical and Biophysical Research Communications, June 2006, Elsevier

    Dirk Wagner

  63. "Mycobacterium tilburgii" Infections

    Article • Emerging Infectious Diseases, March 2006, Centers for Disease Control and Prevention (CDC)

    Dirk Wagner

  64. Perforation of a Dacron vascular endoprosthesis into the duodenum

    Article • Endoscopy, January 2006, Thieme Publishing Group

    Dirk Wagner

  65. Breakthrough Invasive Infection Due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a Stem Cell Transplant Patient Receiving Liposomal Amphotericin B and Caspofungin for Suspected Aspergillosis

    Article • Infection, October 2005, Springer Science + Business Media

    Dirk Wagner

  66. fecB, a gene potentially involved in iron transport inMycobacterium avium, is not induced within macrophages

    Article • FEMS Microbiology Letters, June 2005, Oxford University Press (OUP)

    Dirk Wagner

  67. Infektionen nach Organtransplantation

    Article • Der Internist, June 2005, Springer Science + Business Media

    Dirk Wagner

  68. Elemental Analysis of Mycobacterium avium-, Mycobacterium tuberculosis-, and Mycobacterium smegmatis-Containing Phagosomes Indicates Pathogen-Induced Microenvironments within the Host Cell's Endosomal System

    Article • The Journal of Immunology, January 2005, The American Association of Immunologists

    Dirk Wagner

  69. Changes of the phagosomal elemental concentrations by Mycobacterium tuberculosis Mramp

    Article • Microbiology, January 2005, Society for General Microbiology

    Dirk Wagner

  70. Nosocomial Acquisition of Dengue

    Article • Emerging Infectious Diseases, October 2004, Centers for Disease Control and Prevention (CDC)

    Dirk Wagner

  71. Nontuberculous Mycobacterial Infections: A Clinical Review

    Article • Infection, October 2004, Springer Science + Business Media

    Dirk Wagner

  72. Differential gene expression in mononuclear phagocytes infected with pathogenic and non-pathogenic mycobacteria

    Article • Clinical & Experimental Immunology, June 2004, Wiley

    Dirk Wagner

  73. Trace metals and their relation to bacterial infections studied by X-ray microscopy

    Article • Journal de Physique IV (Proceedings), March 2003, EDP Sciences

    Dirk Wagner

  74. Killing ofMycobacterium aviumandMycobacterium tuberculosisby a Mycobacteriophage Delivered by a Nonvirulent Mycobacterium: A Model for Phage Therapy of Intracellular Bacterial Pathogens

    Article • The Journal of Infectious Diseases, October 2002, Oxford University Press (OUP)

    Dirk Wagner

  75. The US–Japan Cooperative Medical Science Program Tuberculosis and Leprosy Panel's 36th Annual Research Conference, New Orleans, Louisiana, USA, 15–17 July 2001

    Article • Tuberculosis, June 2002, Elsevier

    Dirk Wagner

  76. Characterization and expression of secA in Mycobacterium avium

    Article • FEMS Microbiology Letters, April 2001, Oxford University Press (OUP)

    Dirk Wagner

  77. Characterization and expression ofsecAinMycobacterium avium

    Article • FEMS Microbiology Letters, April 2001, Oxford University Press (OUP)

    Dirk Wagner

  78. Mechanisms of Mycobacterium Avium Pathogenesis

    Article • January 2001, Springer Science + Business Media

    Dirk Wagner

  79. Lokalisierte1H-MR-Spektroskopie des Zentralnervensystems bei HIV-positiven Patienten

    Article • Clinical Neuroradiology, June 1999, Springer Science + Business Media

    Dirk Wagner

  80. Peptostreptococcus ivorii -associated Skin Abscess in a HIV-Infected Patient

    Article • Anaerobe, February 1999, Elsevier

    Dirk Wagner

  81. Influence of n-6 and n-3 polyunsaturated fatty acids on the resistance to experimental tuberculosis

    Article • Metabolism, June 1997, Elsevier

    Dirk Wagner

  82. Serum PCR of Pneumocystis carinii DNA in Immunocompromised Patients

    Article • Scandinavian Journal of Infectious Diseases, January 1997, Taylor & Francis

    Dirk Wagner

  83. Liposomal doxorubicin in AIDS-related Kaposi's sarcoma: long-term experiences

    Article • The Clinical Investigator, June 1994, Springer Science + Business Media

    Dirk Wagner

  84. Influence of dietary (n-3)-polyunsaturated fatty acids on leukotriene B4 and prostaglandin E2 synthesis and course of experimental tuberculosis in guinea pigs

    Article • Infection, March 1994, Springer Science + Business Media

    Dirk Wagner

  85. Androgen dependence and tissue specificity of renin messenger RNA expression in mice

    Article • Journal of Hypertension, January 1990, Wolters Kluwer Health

    Dirk Wagner

  86. Quantification of renin mRNA in various mouse tissues by a novel solution hybridization assay

    Article • Journal of Hypertension, March 1988, Wolters Kluwer Health

    Dirk Wagner